AssetMark Inc’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.12M | Buy |
21,147
+1,371
| +7% | +$332K | 0.01% | 575 |
|
|
2025
Q1 | $5.38M | Buy |
19,776
+1,235
| +7% | +$336K | 0.01% | 495 |
|
|
2024
Q4 | $3.42M | Buy |
18,541
+1,383
| +8% | +$255K | 0.01% | 589 |
|
|
2024
Q3 | $3.85M | Sell |
17,158
-1,450
| -8% | -$326K | 0.01% | 495 |
|
|
2024
Q2 | $2.65M | Buy |
18,608
+1,931
| +12% | +$275K | 0.01% | 544 |
|
|
2024
Q1 | $2.61M | Buy |
16,677
+4,781
| +40% | +$748K | 0.01% | 525 |
|
|
2023
Q4 | $2.15M | Buy |
11,896
+1,404
| +13% | +$253K | 0.01% | 522 |
|
|
2023
Q3 | $1.89M | Buy |
10,492
+961
| +10% | +$173K | 0.01% | 514 |
|
|
2023
Q2 | $1.7M | Buy |
9,531
+914
| +11% | +$163K | 0.01% | 508 |
|
|
2023
Q1 | $1.86M | Buy |
8,617
+2,768
| +47% | +$597K | 0.01% | 469 |
|
|
2022
Q4 | $1.29M | Buy |
5,849
+271
| +5% | +$59.6K | 0.01% | 521 |
|
|
2022
Q3 | $752K | Buy |
5,578
+960
| +21% | +$129K | ﹤0.01% | 581 |
|
|
2022
Q2 | $747K | Buy |
4,618
+732
| +19% | +$118K | ﹤0.01% | 567 |
|
|
2022
Q1 | $733K | Buy |
3,886
+2,238
| +136% | +$422K | ﹤0.01% | 545 |
|
|
2021
Q4 | $446K | Buy |
1,648
+1,360
| +472% | +$368K | ﹤0.01% | 561 |
|
|
2021
Q3 | $105K | Buy |
288
+58
| +25% | +$21.1K | ﹤0.01% | 640 |
|
|
2021
Q2 | $79K | Buy |
230
+1
| +0.4% | +$343 | ﹤0.01% | 676 |
|
|
2021
Q1 | $80K | Buy |
229
+35
| +18% | +$12.2K | ﹤0.01% | 656 |
|
|
2020
Q4 | $50K | Buy |
194
+11
| +6% | +$2.84K | ﹤0.01% | 713 |
|
|
2020
Q3 | $52K | Buy |
183
+27
| +17% | +$7.67K | ﹤0.01% | 669 |
|
|
2020
Q2 | $29K | Buy |
156
+2
| +1% | +$372 | ﹤0.01% | 746 |
|
|
2020
Q1 | $19K | Buy |
154
+3
| +2% | +$370 | ﹤0.01% | 887 |
|
|
2019
Q4 | $25K | Sell |
151
-7
| -4% | -$1.16K | ﹤0.01% | 890 |
|
|
2019
Q3 | $19K | Hold |
158
| – | – | ﹤0.01% | 894 |
|
|
2019
Q2 | $20K | Buy |
158
+1
| +0.6% | +$127 | ﹤0.01% | 885 |
|
|
2019
Q1 | $21K | Buy |
+157
| New | +$21K | ﹤0.01% | 877 |
|